These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19573862)

  • 21. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
    He B; Qiao X; Cerutti A
    J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.
    Brownlie R; Zhu J; Allan B; Mutwiri GK; Babiuk LA; Potter A; Griebel P
    Mol Immunol; 2009 Sep; 46(15):3163-70. PubMed ID: 19573927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
    Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
    Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An oligodeoxynucleotide with CCT repeats restrains CpG ODN-induced TLR9 trafficking.
    Zhang X; Sun W; Wu X; Wang H; Yan Y; Guo S; Song D; Li H; Gao S; Wang L; Yu Y; Wang L
    Curr Pharm Biotechnol; 2014; 15(9):780-9. PubMed ID: 25374030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C
    Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional expression of TLR9 in esophageal cancer.
    Zhang Y; Wang Q; Ma A; Li Y; Li R; Wang Y
    Oncol Rep; 2014 May; 31(5):2298-304. PubMed ID: 24647486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CpG ODN 2102 promotes antibacterial immune responses and enhances vaccine-induced protection in golden pompano (Trachinotusovatus).
    Chen X; Wu Y; Qiu Y; Li P; Cao Z; Zhou Y; Sun Y
    Fish Shellfish Immunol; 2023 Jun; 137():108783. PubMed ID: 37137380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of heat shock protein (Hsp)90 beta but not Hsp90 alpha in antiapoptotic effect of CpG-B oligodeoxynucleotide.
    Kuo CC; Liang CM; Lai CY; Liang SM
    J Immunol; 2007 May; 178(10):6100-8. PubMed ID: 17475835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
    Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
    Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9.
    Liu J; Xu C; Liu YL; Matsuo H; Hsieh RP; Lo JF; Tseng PH; Yuan CJ; Luo Y; Xiang R; Chuang TH
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):443-51. PubMed ID: 22560893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
    Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
    Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.
    Pohar J; Lainšček D; Fukui R; Yamamoto C; Miyake K; Jerala R; Benčina M
    J Immunol; 2015 Nov; 195(9):4396-405. PubMed ID: 26416273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR9 activation is defective in common variable immune deficiency.
    Cunningham-Rundles C; Radigan L; Knight AK; Zhang L; Bauer L; Nakazawa A
    J Immunol; 2006 Feb; 176(3):1978-87. PubMed ID: 16424230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.
    Liang X; Moseman EA; Farrar MA; Bachanova V; Weisdorf DJ; Blazar BR; Chen W
    Blood; 2010 Jun; 115(24):5041-52. PubMed ID: 20339095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis.
    Ren T; Wen ZK; Liu ZM; Liang YJ; Guo ZL; Xu L
    Cancer Biol Ther; 2007 Nov; 6(11):1704-9. PubMed ID: 17986857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
    Jurk M; Schulte B; Kritzler A; Noll B; Uhlmann E; Wader T; Schetter C; Krieg AM; Vollmer J
    Immunobiology; 2004; 209(1-2):141-54. PubMed ID: 15481148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
    Suwarti S; Yamazaki T; Svetlana C; Hanagata N
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor 9 regulates tumor necrosis factor-alpha expression by different mechanisms. Implications for osteoclastogenesis.
    Amcheslavsky A; Zou W; Bar-Shavit Z
    J Biol Chem; 2004 Dec; 279(52):54039-45. PubMed ID: 15485822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.